A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis

Background: Bladder cancer is a common urological cancer associated high significant morbidity and mortality rates. Immunotherapy has emerged as a promising treatment option, although response rates vary among patients. Glycosylation has been implicated in tumorigenesis and immune regulation. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinhui, He, Yunbo, Zhou, Weimin, Tang, Zhuoming, Xiao, Zicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560734/
https://www.ncbi.nlm.nih.gov/pubmed/37818187
http://dx.doi.org/10.3389/fphar.2023.1280428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560734/
https://www.ncbi.nlm.nih.gov/pubmed/37818187
http://dx.doi.org/10.3389/fphar.2023.1280428

Ejemplares similares